Regeneron Pharmaceuticals, Inc. (REGN)
NASDAQ·Healthcare·Biotechnology
$969.26
+0.92%
Mkt Cap $83.15B
Analyst Ratings
Buy
30
Hold
11
Sell
0
Price Target (145 analysts)
$827.71
Range $730.00 – $1,030.00
Implied Upside
-14.6%
Consensus $827.71 vs current $969.26